The Georgia Clinical and Translational Science Alliance (GaCTSA) is a compelling partnership of Emory University, Morehouse School of Medicine, the Georgia Institute of Technology and the University of Georgia, a new academic member adding resources and assets to our CTSA. Also key to GaCTSA are our healthcare partners: Emory Healthcare, Morehouse Healthcare, Children?s Healthcare of Atlanta, the Atlanta VA Medical Center, the Grady Health System, and the Atlanta Community Physicians Network and our translational science partners including the Yerkes National Primate Research Center (located at Emory), the Georgia Research Alliance, Georgia Bio and links to the Prevention Research Centers of the US Centers for Disease Control and Prevention (CDC). Built over the past decade of collaboration, the partners of GaCTSA have forged strong research networks and GaCTSA has become a ?24 hour? home and catalyst for innovative, high quality clinical and translational research with local, national and global impact. The addition of UGA allows the GaCTSA to better engage the large, rural and underserved populations of our state and adds new resources, including: outstanding translational research in glycobiology, infectious diseases, One Health, a new clinical and translational research unit, outstanding programs in Education, a School of Pharmacy; a robust extension service that reaches beyond its original agricultural mission to focus on family health; and the Archway Partnership whose mission is to connect Georgia communities with higher education resources to address critical, locally identified community needs. In addition to facilitating innovative science, GaCTSA will encourage collaboration, improve quality and efficiencies, reduce barriers to clinical and translational research and accelerate the process of translating biomedical discoveries into clinical applications. Key to the next funding cycle, GaCTSA will emphasize innovative training and workforce development, access to and integration of special and underserved populations, enhanced biomedical informatics support and capabilities, new methods and processes to improve quality and efficiency, enhanced collaboration and engagement and team-based, quality focused predictive science.
The specific aims of GaCTSA reflect the vision and goals of NCATS Advisory Council Working Group and the recommendations of the 2013 IOM review of the CTSA program. The GaCTSA?s specific aims will serve as guiding principles to drive the vision and approach.

Public Health Relevance

Created in response to the NIH CTSA program, the Georgia Clinical & Translational Science Alliance (GaCTSA) serves as a catalyst and incubator for clinical and translational research across Georgia and with regional and national impact. In addition to facilitating innovative science, we will encourage collaboration, improve quality and efficiencies, reduce barriers to clinical and translational research, and accelerate the process of translating biomedical discoveries into clinical applications.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
5UL1TR002378-02
Application #
9569744
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Davis Nagel, Joan
Project Start
2017-09-22
Project End
2022-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Emory University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Chinnadurai, Raghavan; Rajan, Devi; Qayed, Muna et al. (2018) Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach. Cell Rep 22:2504-2517
Dunlop, Boadie W; Cole, Steven P; Nemeroff, Charles B et al. (2018) Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder. J Affect Disord 229:111-119
Serota, David P; Franch, Harold A; Cartwright, Emily J (2018) Acute Kidney Injury in a Patient on Tenofovir Alafenamide Fumarate After Initiation of Treatment for Hepatitis C Virus Infection. Open Forum Infect Dis 5:ofy189
Graciaa, D S; Machaidze, M; Kipiani, M et al. (2018) A survey of the tuberculosis physician workforce in the country of Georgia. Int J Tuberc Lung Dis 22:1286-1292
Gopalsamy, Srinivasa Nithin; Sherman, Amy; Woodworth, Michael H et al. (2018) Fecal Microbiota Transplant for Multidrug-Resistant Organism Decolonization Administered During Septic Shock. Infect Control Hosp Epidemiol 39:490-492
Hohos, Natalie M; Smith, Alicia K; Kilaru, Varun et al. (2018) CD4+ and CD8+ T-Cell-Specific DNA Cytosine Methylation Differences Associated With Obesity. Obesity (Silver Spring) 26:1312-1321
Squires, Alexander; Oshinski, John N; Boulis, Nicholas M et al. (2018) SpinoBot: An MRI-Guided Needle Positioning System for Spinal Cellular Therapeutics. Ann Biomed Eng 46:475-487
Morris, Claudia R; Mauger, David T; Suh, Jung H et al. (2018) Glutathione and arginine levels: Predictors for acetaminophen-associated asthma exacerbation? J Allergy Clin Immunol 142:308-311.e9
Burke, Rachel M; Rebolledo, Paulina A; Aceituno, Anna M et al. (2018) Effect of infant feeding practices on iron status in a cohort study of Bolivian infants. BMC Pediatr 18:107
Woodworth, Michael H; Kraft, Colleen S; Meredith, Erika J et al. (2018) Tacrolimus concentration to dose ratio in solid organ transplant patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. Transpl Infect Dis 20:e12857

Showing the most recent 10 out of 87 publications